NCT02609126 - Safety Study of a Long-Acting Injectable Steroid to Treat Knee Osteoarthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 28, 2017

Study Completion Date

December 28, 2017

Conditions

Osteoarthritis, Knee

Interventions

DRUG

EP-104IAR

Single, ultrasound-guided injection of EP-104IAR into the knee

DRUG

Vehicle

Single, ultrasound-guided injection of vehicle placebo into the knee

Trial Locations (3)

Rebalance MD, Victoria

Centre for Studies in Family Medicine, London

Fowler Kennedy Sports Medicine Clinic, London